Johnson & Johnson clears a key OTTAVA hurdle, but the harder robotics test comes next
Robotic surgery is opening up. Johnson & Johnson’s OTTAVA data may test whether hospitals want a new soft tissue platform.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Why Johnson & Johnson’s new ETHICON 4000 stapler could matter for European surgical workflow economics
Read how Johnson & Johnson’s ETHICON 4000 CE Mark approval could reshape surgical stapling, hospital economics, and future robotic integration.
Medical Devices & Diagnostics
What EndoQuest’s PARADIGM Trial approval reveals about robotic ESD innovation in GI surgery
EndoQuest wins FDA approval to complete PARADIGM Trial for its ELS system. Find out what this milestone means for robotic GI surgery innovation.
Medical Devices & Diagnostics
Vicarious Surgical bets on outsourced software execution to control costs and advance clinical timelines
Vicarious Surgical shifts software development to a global partner to cut costs and hit clinical trial milestones. Here’s what this means for its platform.